Physician profile
Jacob Keith Hoffmann
NPI 1811487622
$8,023.15
in general payments reported to CMS, 2019-2025
30 companies · $620 in 2025
The $620 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $337 · 2022: $89.20 · 2023: $4,399 · 2024: $2,577 · 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,176 · Travel and Lodging: $2,322 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,176.11 |
| Travel and Lodging | $2,321.54 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,297.62 | 2023-2025 | Synchromedii, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $1,755.00 | 2023-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Relievant Medsystems, INC. | $1,498.12 | 2023 | Intracept |
| Mml US, INC. | $352.89 | 2023-2025 | Reactiv8 |
| Saluda Medical Americas, INC. | $338.09 | 2024 | Evoke |
| Stryker Corporation | $247.80 | 2021-2022 | |
| Abbvie INC. | $209.99 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $197.11 | 2023-2025 | Xtampza, Belbuca |
| Depuy Synthes Sales INC. | $178.26 | 2021-2024 | Monovisc, Orthovisc, Peak |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $109.78 | 2023-2024 | Relistor |
| Vertos Medical, INC. | $100.00 | 2023 | Mild Device Kit |
| Averitas Pharma INC. | $93.33 | 2023-2025 | Qutenza |
| Nalu Medical, INC. | $81.99 | 2023-2024 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $77.07 | 2024-2025 | Sprint Pns System |
| Painteq LLC | $74.41 | 2023 | Painteq |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $70.54 | 2023-2025 | Xeomin |
| Lundbeck LLC | $54.18 | 2023-2024 | Vyepti |
| Almatica Pharma LLC | $35.82 | 2023 | Gralise |
| Ermi LLC | $34.59 | 2021 | |
| Impel Pharmaceuticals INC. | $27.03 | 2023 | Trudhesa |
| Hydrocision, INC. | $26.89 | 2025 | Tenjet |
| Ferring Pharmaceuticals INC. | $26.21 | 2021-2022 | |
| Inspire Medical Systems, INC. | $25.37 | 2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $23.50 | 2023 | |
| Indivior INC. | $21.12 | 2023 | Sublocade |
| Lucid Diagnostics INC. | $16.31 | 2022 | |
| Idorsia Pharmaceuticals US INC | $13.60 | 2023 | Quviviq |
| International Rehabilitative Sciences, INC | $12.81 | 2023 | Rs 4i Plus Sequential Stimulator |
| Lilly USA, LLC | $12.12 | 2022 | |
| Davol INC. | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Hoffmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.